How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Using the right study materials can help strengthen the skills required to crack technical interviews in 2026. They aid in strengthening problem-solving skills, ...

随着网络犯罪生态系统的演进，信息窃取器（Infostealers）已从零散的攻击工具发展为高度模块化、产业化的恶意软件即服务（MaaS）产品。此类恶意代码不同于勒索软件的破坏性特征，其核心在于“静默潜伏”与“高效萃取”，旨在无感知地窃取用户凭证、会话 ...